Sign In
Buy ONTX
$1.00
+0 (+0%)
At Close: Jul 01, 2024
ONTX Stock Price Increases 4% Pre-Market: Why It Happened
09:06am, Monday, 01'st Mar 2021
The stock price of Onconova Therapeutics Inc (NASDAQ: ONTX) increased by 4% pre-market. This is why it happened.
Onconova Therapeutics to Participate in Three Investment Conferences During the Month of March
08:00am, Monday, 01'st Mar 2021
NEWTOWN, PA., March 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patie
Onconova Therapeutics Shares Trading Higher Following Regained Compliance With NASDAQ Listing Requirements
04:37pm, Wednesday, 24'th Feb 2021
Onconova Therapeutics (NASDAQ: ONTX) shares are trading higher today after the company announced it regained compliance with the Nasdaq listing requirement. Onconova Therapeutics, Inc. is a biopharmac
Onconova Therapeutics: Understanding ON12330 And Inhibition Of CDK4/6 And ARK5 In Breast Cancer
03:04pm, Friday, 19'th Feb 2021
Overview of Onconova Therapeutics, including pipeline, balance sheet, and recent bullish stock price action.
Why Onconova Therapeutics Stock Soared Today
05:51pm, Wednesday, 17'th Feb 2021
Investors are eager to hear more about the biotech's experimental cancer treatments.
ONTX Stock: Why Biopharma Onconova Therapeutics Is Shooting Higher Today
11:52am, Wednesday, 17'th Feb 2021
Onconova Therapeutics (ONTX) stock is on the rise Wednesday following the closing of its most recent public offering of 28.75 million shares. The post ONTX Stock: Why Biopharma Onconova Therapeutics I
ONTX Stock Price Increases Over 30%: Why It Happened
11:21am, Wednesday, 17'th Feb 2021
The stock price of Onconova Therapeutics Inc (NASDAQ: ONTX) as of 11:17 PM ET. This is why it happened.
NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat c
Onconova Therapeutics to Present Corporate Update at the 2021 BIO CEO & Investor Digital Conference
08:00am, Tuesday, 16'th Feb 2021
NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patien
Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
10:49pm, Wednesday, 10'th Feb 2021
NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat c
Onconova Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
04:01pm, Wednesday, 10'th Feb 2021
NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat c
ONTX Stock Price Increases 25%: Why It Happened
05:04pm, Wednesday, 03'rd Feb 2021
The stock price of Onconova Therapeutics Inc (NASDAQ: ONTX) has increased by 25% today. This is why it happened.
Onconova Therapeutics, Inc. Announces $8.7 Million Public Offering
09:40am, Thursday, 07'th Jan 2021
NEWTOWN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat c
Onconova Therapeutics: 7 Things for ONTX Stock Investors to Know About the Biopharma
01:06pm, Tuesday, 01'st Dec 2020
Onconova Therapeutics (ONTX) stock is on the move Tuesday with heavy trading despite a lack of recent news from the company. The post Onconova Therapeutics: 7 Things for ONTX Stock Investors to Know A
Onconova Therapeutics Files Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
08:00am, Monday, 23'rd Nov 2020
NEWTOWN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today anno
